Loading…

Evaluation of the Effectiveness of a Short Term Treatment and Repeat Treatment of Nocturnal Enuresis Using an Enuresis Alarm

Abstract Objective To evaluate the effectiveness of a 3-month enuresis alarm (EA) treatment and repeat EA treatment among pediatric patients with nocturnal enuresis (NE), and to compare patient characteristics among ‘responders’ and ‘non-responders’ to treatment. Materials and Methods Clinical outco...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 2017-07, Vol.105, p.153-156
Main Authors: Hyuga, Taiju, Nakamura, Shigeru, Kawai, Shina, Nakai, Hideo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective To evaluate the effectiveness of a 3-month enuresis alarm (EA) treatment and repeat EA treatment among pediatric patients with nocturnal enuresis (NE), and to compare patient characteristics among ‘responders’ and ‘non-responders’ to treatment. Materials and Methods Clinical outcomes were retrospectively evaluated for 137 children (94 boys and 43 girls, mean age, 10.1 years). Effectiveness was evaluated after an initial 3-month treatment, using the International Children's Continence Society criteria. Among children in the no response (NR) group at 3 months, those who continued the EA treatment for ≥4 months were subclassified into group 1, while children who repeated the EA treatment at an interval ≥6 months were subclassified into group 2. Results Among our 137 cases, 19 achieved complete response (CR) and 47 partial response (PR) at 3 months, for an overall treatment effectiveness rate of 48%. Among the NR group, treatment was extended in 17 cases (group 1), with 3 (18%) achieving a successful outcome. Treatment was repeated in 18 cases (group 2). In group 2, successful outcome was 8 (44%) at 3-month time point. Daytime urinary incontinence did not modify treatment effectiveness. Conclusions EA treatment should be given for a short period of time and should not be continued without a definite purpose or clear response. Suspending and then repeating this treatment after an appropriate interval is effective for patients who do not respond to the initial course of treatment.
ISSN:0090-4295
1527-9995
DOI:10.1016/j.urology.2017.01.005